Heavy Short Flow in IBRX
ImmunityBio (IBRX) is currently experiencing significant short-selling activity, with a 30.5% short volume ratio reported in recent sessions. The stock has been flagged on the FINRA Reg-SHO threshold list, indicating that failures-to-deliver have crossed regulatory thresholds for at least five consecutive days. This is a critical signal that real covering pressure is building in the tape. With a borrow fee of 0.6% and a days-to-cover ratio of 7.7, the stock remains a focal point for short sellers. Traders should monitor the borrow availability closely, as any further tightening in supply could lead to increased volatility.
Signal data sourced from Tapeboard. This post is an original analysis prepared by The Forensic Ledger from publicly available data. Not investment advice.
Not investment advice. This is original reporting and analysis prepared by The Forensic Ledger from publicly available data. Nothing here is a recommendation to buy, sell, or hold any security. Always consult the original source and a licensed professional. See our full disclaimer and source-citation policy.